|Project Title||Intussusception Risk after Rotavirus Vaccination in U.S. Infants|
Thursday, February 6, 2014
This article describes the findings of a study conducted to evaluate the risk of intussusception associated with two Rotavirus vaccines, Rotateq (RV5) and Rotarix (RV1), in infants 5 to 30.9 weeks of age in the United States.
|Population / Cohort||
All infants 5 to 30.9 weeks of age
Mini-Sentinel Distributed Database (MSDD)
- Vaccines, Blood & Biologics
- Devices and Radiologic Health